FDA’s Schwartz Says New Draft Cybersecurity Guidance Addresses Emerging Threats

Agency shifts focus to software, removes tiered risk assessments

 
• By Brian Bossetta
Suzanne Schwartz is director of the Office of Strategic Partnerships & Technology Innovation at the Center for Devices & Radiological Health.
SUZANNE SCHWARTZ • Source: FDA

More from Regulation

More from Policy & Regulation